Is Riluzole Oral Suspension (Teglutik) in shortage?
Yes. Riluzole Oral Suspension is on FDA’s drug shortage list (unavailable), last updated Oct 1, 2026.
Why it’s in shortage
- Requirements related to complying with good manufacturing practices
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)
Estimated recovery: TBD
Maker contact: 610-937-6172
- Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)
Maker contact: 610-937-6172
- Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)
Maker contact: 610-937-6172
- Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)
Maker contact: 610-937-6172
FDA recalls of Riluzole
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Riluzole Oral Suspension:
Riluzole Oral Suspension shortage questions
Is Riluzole Oral Suspension (Teglutik) in shortage?
Yes. Riluzole Oral Suspension is on FDA’s drug shortage list (unavailable), last updated Oct 1, 2026.
Why is there a Riluzole Oral Suspension shortage?
FDA records the reason as: Requirements related to complying with good manufacturing practices.
What should I do if I can’t get Riluzole Oral Suspension?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.